We report 1,327 probable cases of dengue in Burkina Faso in 2016. Of 35 serum samples tested by a trioplex test, 19 were confirmed dengue virus (DENV)‒positive: 11 DENV-2, 6 DENV-3, 2 nontypeable, and 1 DENV-2/DENV-3 co-infection. Molecular testing should be conducted to correctly identify causative agents in this complex infectious disease landscape.
Keywords: Burkina Faso; DENV-2; DENV-3; dengue; dengue fever; disease control; molecular diagnosis; reemerging dengue fever; reemerging diseases; serologic diagnosis; vector-borne infections; viruses.